Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical FP1198 (Danazol) for Cyclic Mastalgia
NCT01105793Phase 2Completed
- Sponsor
- FemmePharma
- Start
- Jun 2010
- Primary completion
- Jun 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of danazol in cyclic mastalgia, sponsored by FemmePharma. Primary endpoint: Reduction in breast pain at 6 months. Started Jun 2010; status: completed.
02
Drugs
danazol
03
Conditions
cyclic mastalgia
Beyond the preview
Go deeper on NCT01105793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01105793.